Quantitative lung ultrasound to guide poractant-alpha administration in late preterm and term neonates with respiratory failure

Monday, May 6, 2024

1:30 PM – 1:45 PM ET

Location: Metro Toronto Convention Centre: 201 BD

CE Enduring CME: 0.25

Publication Number: 3080.3

Daniele De Luca, APHP-Paris Saclay University, Paris, Ile-de-France, France; Francesco Vinci, Gaslini Institute, Genoa, Liguria, Italy; Reedhi Dasani, Stanford University School of Medicine, Mountain View, CA, United States; Barbara Loi, Paris Saclay University, Paris, Ile-de-France, France; Diletta Martino, Antoine Beclere Hospital, Paris saclay university, Paris, Ile-de-France, France; Almudena Alonso-Ojembarrena, Puerta del Mar University Hospital, San Fernando, Andalucia, Spain; Alexis S.. Davis, Stanford University, Palo Alto, CA, United States

Presenting Author(s)

Daniele De luca, MD, PhD (he/him/his)
Full Professor of Neonatology
Paris Saclay University
Clamart, Ile-de-France, France

Slides

Disclosure(s):

Daniele De luca, MD, PhD: Airway Therapeutics (Ongoing) (Products/Services: Advisory Committee); Astra Zeneca (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); CHIESI (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator, Speaker Honorarium including speakers bureau, symposia, and expert witness); Medtronic (Ongoing) (Products/Services: Consultant, Speaker Honorarium including speakers bureau, symposia, and expert witness); OPHIREX (Ongoing) (Products/Services: Advisory Committee, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Radiometer (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); VYAIRE (Ongoing) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness)